Related Experiment Video
Updated: May 17, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
miR-10b*, a master inhibitor of the cell cycle, is down-regulated in human breast tumours
Francesca Biagioni1, Noa Bossel Ben-Moshe, Giulia Fontemaggi
1Translational Oncogenomic Unit, Regina Elena National Cancer Institute, Rome, Italy.
Abstract:
Deregulated proliferation is a hallmark of cancer cells. Here, we show that microRNA-10b* is a master regulator of breast cancer cell proliferation and is downregulated in tumoural samples versus matched peritumoural counterparts. Two canonical CpG islands (5 kb) upstream from the precursor sequence are hypermethylated in the analysed breast cancer tissues. Ectopic delivery of synthetic microRNA-10b* in breast cancer cell lines or into xenograft mouse breast tumours inhibits cell proliferation and impairs tumour growth in vivo, respectively. We identified and validated in vitro and in vivo three novel target mRNAs of miR-10b* (BUB1, PLK1 and CCNA2), which play a remarkable role in cell cycle regulation and whose high expression in breast cancer patients is associated with reduced disease-free survival, relapse-free survival and metastasis-free survival when compared to patients with low expression. This also suggests that restoration of microRNA-10b* expression might have therapeutic promise.
Related Concept Videos
MicroRNAs
MicroRNAs
Inhibition of Cdk Activity
Inhibition of CDK Activity
Abnormal Proliferation
Mitogens and the Cell Cycle

